Tenax Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.
/ 
Others were interested in
Frequently asked questions
To buy Tenax Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Tenax Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Tenax Therapeutics Inc. is TENX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Tenax Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade Tenax Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Tenax Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Tenax Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Tenax Therapeutics Inc. or others.